Onex Canada Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-33,241
| Closed | -$957K | – | 123 |
|
|
2023
Q4 | $957K | Sell |
33,241
-56,558
| -63% | -$1.71M | 0.09% | 122 |
|
|
2023
Q3 | $2.98M | Sell |
89,799
-13,800
| -13% | -$488K | 0.23% | 107 |
|
|
2023
Q2 | $3.8M | Sell |
103,599
-16,225
| -14% | -$632K | 0.23% | 104 |
|
|
2023
Q1 | $4.89M | Sell |
119,824
-69,155
| -37% | -$2.99M | 0.27% | 95 |
|
|
2022
Q4 | $9.68M | Buy |
188,979
+2,695
| +1% | +$129K | 0.54% | 61 |
|
|
2022
Q3 | $8.15M | Sell |
186,284
-1,786
| -0.9% | -$86.8K | 0.49% | 63 |
|
|
2022
Q2 | $9.86M | Buy |
188,070
+12,939
| +7% | +$659K | 0.54% | 56 |
|
|
2022
Q1 | $9.07M | Buy |
175,131
+26,163
| +18% | +$1.36M | 0.39% | 73 |
|
|
2021
Q4 | $8.8M | Buy |
148,968
+7,813
| +6% | +$387K | 0.36% | 80 |
|
|
2021
Q3 | $6.07M | Buy |
141,155
+195
| +0.1% | +$8.64K | 0.25% | 104 |
|
|
2021
Q2 | $5.52M | Buy |
140,960
+422
| +0.3% | +$16.4K | 0.25% | 98 |
|
|
2021
Q1 | $5.09M | Sell |
140,538
-75,602
| -35% | -$2.68M | 0.23% | 113 |
|
|
2020
Q4 | $7.96M | Sell |
216,140
-14,436
| -6% | -$530K | 0.55% | 65 |
|
|
2020
Q3 | $8.03M | Sell |
230,576
-16,947
| -7% | -$594K | 0.53% | 64 |
|
|
2020
Q2 | $7.68M | Sell |
247,523
-161,975
| -40% | -$5.5M | 0.51% | 62 |
|
|
2020
Q1 | $12.7M | Buy |
409,498
+144,313
| +54% | +$4.92M | 0.84% | 34 |
|
|
2019
Q4 | $9.66M | Sell |
265,185
-51
| -0% | -$1.82K | 0.55% | 57 |
|
|
2019
Q3 | $9.04M | Buy |
265,236
+259,211
| +4,302% | +$9.43M | 0.57% | 54 |
|
|
2019
Q2 | $248K | Hold |
6,025
| – | – | 0.01% | 108 |
|
|
2019
Q1 | $243K | Sell |
6,025
-822,119
| -99% | -$32.9M | 0.01% | 108 |
|
|
2018
Q4 | $34.3M | Sell |
828,144
-11,987
| -1% | -$498K | 2.22% | 19 |
|
|
2018
Q3 | $35.1M | Sell |
840,131
-139,776
| -14% | -$5.38M | 1.55% | 29 |
|
|
2018
Q2 | $33.7M | Sell |
979,907
-91,949
| -9% | -$3.14M | 1.7% | 27 |
|
|
2018
Q1 | $36.1M | Buy |
1,071,856
+336,859
| +46% | +$11.6M | 1.96% | 23 |
|
|
2017
Q4 | $25.3M | Sell |
734,997
-10,146
| -1% | -$346K | 1.32% | 30 |
|
|
2017
Q3 | $25.2M | Sell |
745,143
-79,528
| -10% | -$2.56M | 2.6% | 19 |
|
|
2017
Q2 | $26.3M | Sell |
824,671
-1,791
| -0.2% | -$56.5K | 2.4% | 16 |
|
|
2017
Q1 | $26.8M | Buy |
826,462
+43,414
| +6% | +$1.37M | 2.35% | 15 |
|
|
2016
Q4 | $24.1M | Sell |
783,048
-14,524
| -2% | -$443K | 2.12% | 20 |
|
|
2016
Q3 | $25.1M | Buy |
+797,572
| New | +$26.7M | 2.37% | 18 |
|
|
2015
Q3 | – | Sell |
-6,636
| Closed | -$263K | – | 91 |
|
|
2015
Q2 | $263K | Buy |
+6,636
| New | +$216K | 0.01% | 69 |
|
|
2014
Q2 | – | Sell |
-1,821,865
| Closed | -$55.5M | – | 92 |
|
|
2014
Q1 | $55.5M | Buy |
1,821,865
+192,386
| +12% | +$5.74M | 3.56% | 6 |
|
|
2013
Q4 | $47.4M | Buy |
1,629,479
+744,029
| +84% | +$21.7M | 2.54% | 11 |
|
|
2013
Q3 | $24.1M | Sell |
885,450
-94,680
| -10% | -$2.58M | 1.52% | 25 |
|
|
2013
Q2 | $27.4M | Buy |
+980,130
| New | +$27.1M | 1.79% | 18 |
|
Other funds holding PFE
Onex Canada Asset Management's PFE Position: Q1 2024 in Review
Onex Canada Asset Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 33,241 shares — an estimated $957K sold.
Onex Canada Asset Management first reported a position in PFE in Q2 2013 and held it in 35 quarters. The position peaked at $55.5M in Q1 2014. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Onex Canada Asset Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
- Onex Canada Asset Management sold 33,241 Pfizer shares in Q1 2024, an estimated $957K.
- Onex Canada Asset Management first reported a position in Pfizer in Q2 2013 and held it in 35 quarters.
- Onex Canada Asset Management's Pfizer position peaked at $55.5M in Q1 2014.
- 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Onex Canada Asset Management's 13F filing for Q1 2024, filed 15 May 2024.